14-03-2025 15:37 via medpagetoday.com

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

(MedPage Today) -- SAN FRANCISCO--A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
Read more »

Medical news



Dementia Drug Doesn't Help Long COVID Fatigue, Psychological Symptoms
Spironolactone Gains Foothold in Acne Amid Unresolved Safety Questions
Diagnosing Pediatric and Late-Onset Multiple Sclerosis
Do Adults Need a Measles Booster?
Why CDC's Planned Vaccine-Autism Study Is Raising Eyebrows
Is E-Competency the Same as Competency?
Senior Investigator David Landsman, PhD, Selected as International Society for Computational Biology Fellow
Senior Investigator David Landsman, PhD, Selected as International Society for Computational Biology Fellow
Could Updating Urine Drug Screenings in Pregnancy Reduce Racial Inequities?
Statin Use Linked With Reduced Risks in Chronic Liver Disease
Adenotonsillectomy for Snoring in Kids Tied to Reduced Healthcare Use Later On
As AI Nurses Reshape Hospital Care, Human Nurses Are Pushing Back
I Didn't Match. What Do I Do Now?
A Promising Future for Metastasis-Directed Therapy in Prostate Cancer
NIH Removes Fauci Mural; Trump Deports Doctor; FDA Crackdown on Poppers?
Desktop versie